Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-E in psoriasis susceptibility

Experimental Dermatology

Volumn 22, Issue 10, 2013, Pages 679-681

  Zeng, Xue ^a,b   Chen, Haoyan ^a,c   Gupta, Rashmi ^a   Paz Altschul, Oscar ^a   Bowcock, Anne M ^d   Liao, Wilson ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

HLA E; KLRC2; Natural killer; NKG2C; Psoriasis

Indexed keywords

HLA E ANTIGEN;

ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; NATURAL KILLER CELL; PSORIASIS;

HLA-E; KLRC2; NATURAL KILLER; NKG2C; PSORIASIS;

ALLELES; CASE-CONTROL STUDIES; COHORT STUDIES; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; LIGANDS; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PSORIASIS; RISK FACTORS;

EID: 84884718080     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/exd.12233     Document Type: Article

References (29)

1. Nestle F O, Kaplan D H, Barker J. N Engl J Med 2009: 361: 496-509.
2. Fujiwara S, Nagai H, Oniki S et al. Exp Dermatol 2012: 21: 70-72.
3. Dunphy S, Gardiner C M. J Biomed Biotechnol 2011: 2011: 248317.
4. Ottaviani C, Nasorri F, Bedini C et al. Eur J Immunol 2006: 36: 118-128.
5. Holm S J, Sakuraba K, Mallbris L et al. J Invest Dermatol 2005: 125: 721-730.
6. Luszczek W, Manczak M, Cislo M et al. Hum Immunol 2004: 65: 758-766.
7. Suzuki Y, Hamamoto Y, Ogasawara Y et al. J Invest Dermatol 2004: 122: 1133-1136.
8. Chen H, Hayashi G, Lai O Y et al. PLoS Genet 2012: 8: e1002514.
9. Nelson G W, Martin M P, Gladman D et al. J Immunol 2004: 173: 4273-4276.
10. Miyashita R, Tsuchiya N, Hikami K et al. Int Immunol 2004: 16: 163-168.
11. Thomas R, Low H Z, Kniesch K et al. AIDS Res Hum Retroviruses 2012: 28: 844-851.
12. Paquay M M, Schellekens J, Tilanus M G. Tissue Antigens 2009: 74: 514-519.
13. Carlen L. Study of the psoriasis proteome and analysis of MHC class I expression and function. 2008: Available at: http://www.dissertations.se/dissertation/4f6ecbf052/.
14. Lang P A, Lang K S, Xu H C et al. Proc Natl Acad Sci USA 2012: 109: 1210-1215.
15. Waggoner S N, Cornberg M, Selin L K et al. Nature 2012: 481: 394-398.
16. Matsumoto Y, Kohyama K, Aikawa Y et al. Eur J Immunol 1998: 28: 1681-1688.
17. Zhang B, Yamamura T, Kondo T et al. J Exp Med 1997: 186: 1677-1687.
18. Xu W, Fazekas G, Hara H et al. J Neuroimmunol 2005: 163: 24-30.
19. Yamaji O, Nagaishi T, Totsuka T et al. J Immunol 2012: 188: 2524-2536.
20. Batista M D, Ho E L, Kuebler P J et al. Exp Dermatol 2013: 22: 64-66.
21. Gilhar A, Keren A, Shemer A et al. J Invest Dermatol 2013: 133: 844-847.
22. Ito T, Ito N, Saatoff M et al. J Invest Dermatol 2008: 128: 1196-1206.
23. Petukhova L, Duvic M, Hordinsky M et al. Nature 2010: 466: 113-117.
24. Paladini F, Belfiore F, Cocco E et al. Arthritis Res Ther 2009: 11: R171.
25. Hodgkinson A D, Millward B A, Demaine A G. Hum Immunol 2000: 61: 290-295.
26. Park K S, Park J S, Nam J H et al. Tissue Antigens 2007: 69: 139-144.
27. Gooden M, Lampen M, Jordanova E S et al. Proc Natl Acad Sci USA 2011: 108: 10656-10661.
28. Strange A, Capon F, Spencer C C et al. Nat Genet 2010: 42: 985-990.
29. Morel E, Escamochero S, Cabanas R et al. J Allergy Clin Immunol 2010: 125: 703-710, 710 e701-710 e708.